miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A

Mingchen Shao1, Yiwei Geng1, Peng Lu2

  • 1Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Laboratory of Tumor Biology, Zhengzhou University, Zhengzhou, China.

Insights

MicroRNAs (miRNAs) promote anaplastic thyroid carcinoma (ATC) cell growth and invasion by targeting CDKN1A. Inhibiting miR-4295 could be a therapeutic strategy for ATC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
  • The specific role of miRNAs in anaplastic thyroid carcinoma (ATC) pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the function of miR-4295 in anaplastic thyroid carcinoma (ATC).
  • To identify the target gene of miR-4295 and its role in ATC progression.

Main Methods:

  • Cell proliferation was assessed using CCK-8 assays.
  • Cell migration and invasion were evaluated via Transwell assays.
  • Target gene validation involved luciferase assays and Western blotting.

Main Results:

  • miR-4295 overexpression promoted ATC cell proliferation, migration, and invasion.
  • miR-4295 directly targeted and suppressed CDKN1A expression at the protein level.
  • Inhibiting miR-4295 significantly reduced ATC cell proliferation and invasion.

Conclusions:

  • miR-4295 promotes ATC progression by negatively regulating CDKN1A.
  • miR-4295 represents a potential therapeutic target for anaplastic thyroid carcinoma intervention.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K